首页 > 最新文献

JMA journal最新文献

英文 中文
Loneliness and its Determinants in Mothers Raising Infants in Central Tokyo. 东京中部养育婴儿的母亲的孤独感及其决定因素。
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-11-14 DOI: 10.31662/jmaj.2025-0156
Emilie Louise Akiko Matsumoto-Takahashi, Yuko Matsuoka, Toshiko Eto

Introduction: In Japan, suicide is the most common cause of death among women who die in the first year after childbirth. This study aimed to analyze the loneliness of mothers raising infants in central Tokyo and to provide evidence for improving maternal mental health.

Methods: Fieldwork was conducted from June to September 2024, and questionnaire surveys were administered to 104 mothers who visited childcare support groups in Setagaya ward, Tokyo. Survey items were socioeconomic indicators and the Japanese version of the University of California, Los Angeles (UCLA) loneliness Scale Version 3 (UCLA-LS3-J), containing 20 items. Structured equation modeling (SEM) was conducted to analyze differences in loneliness by mother and infant characteristics.

Results: The average age of the mothers was 34.4 years, and that of their youngest child was 9.8 months. Among them, 24.0% of the mothers had a UCLA-LS3-J score >40 (which is considered moderate to high in terms of loneliness). SEM identified three factors independently associated with loneliness: health status, daily use of a nursery school or kindergarten, and the number of people the mothers could consult (p <0.05). Specifically, loneliness of the mothers was significantly higher when they were feeling less healthy, not using a nursery school or kindergarten, and having fewer people that they could consult.

Conclusions: Some mothers felt particularly isolated, and an intervention to strengthen consultation could be effective in improving loneliness of the mothers living in central Tokyo. Moreover, promotion of the use of nursery schools or kindergartens is also expected to improve the mothers' mental health.

导读:在日本,在分娩后第一年死亡的女性中,自杀是最常见的死因。本研究旨在分析东京市中心养育婴儿的母亲的孤独感,为改善母亲的心理健康提供证据。方法:于2024年6 - 9月进行实地调查,对访问东京世田谷区托儿支持团体的104名母亲进行问卷调查。调查项目为社会经济指标和日文版加州大学洛杉矶分校(UCLA)孤独感量表第3版(UCLA- ls3 - j),共20个项目。采用结构方程模型(SEM)分析母亲和婴儿在孤独感方面的差异。结果:母亲平均年龄34.4岁,最小子女平均年龄9.8个月。其中,24.0%的母亲的UCLA-LS3-J得分为40分(在孤独感方面被认为是中至高)。SEM发现了与孤独感独立相关的三个因素:健康状况、托儿所或幼儿园的日常使用情况以及母亲可以咨询的人数(p)。结论:一些母亲感到特别孤立,加强咨询的干预措施可以有效改善东京市中心母亲的孤独感。此外,促进使用托儿所或幼儿园也有望改善母亲的心理健康。
{"title":"Loneliness and its Determinants in Mothers Raising Infants in Central Tokyo.","authors":"Emilie Louise Akiko Matsumoto-Takahashi, Yuko Matsuoka, Toshiko Eto","doi":"10.31662/jmaj.2025-0156","DOIUrl":"https://doi.org/10.31662/jmaj.2025-0156","url":null,"abstract":"<p><strong>Introduction: </strong>In Japan, suicide is the most common cause of death among women who die in the first year after childbirth. This study aimed to analyze the loneliness of mothers raising infants in central Tokyo and to provide evidence for improving maternal mental health.</p><p><strong>Methods: </strong>Fieldwork was conducted from June to September 2024, and questionnaire surveys were administered to 104 mothers who visited childcare support groups in Setagaya ward, Tokyo. Survey items were socioeconomic indicators and the Japanese version of the University of California, Los Angeles (UCLA) loneliness Scale Version 3 (UCLA-LS3-J), containing 20 items. Structured equation modeling (SEM) was conducted to analyze differences in loneliness by mother and infant characteristics.</p><p><strong>Results: </strong>The average age of the mothers was 34.4 years, and that of their youngest child was 9.8 months. Among them, 24.0% of the mothers had a UCLA-LS3-J score >40 (which is considered moderate to high in terms of loneliness). SEM identified three factors independently associated with loneliness: health status, daily use of a nursery school or kindergarten, and the number of people the mothers could consult (<i>p</i> <0.05). Specifically, loneliness of the mothers was significantly higher when they were feeling less healthy, not using a nursery school or kindergarten, and having fewer people that they could consult.</p><p><strong>Conclusions: </strong>Some mothers felt particularly isolated, and an intervention to strengthen consultation could be effective in improving loneliness of the mothers living in central Tokyo. Moreover, promotion of the use of nursery schools or kindergartens is also expected to improve the mothers' mental health.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"68-76"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889598/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication Reduction is Associated with Improved Activities of Daily Living and Muscle Strength in Post-Stroke Patients with Polypharmacy. 减少药物治疗与卒中后多药患者日常生活活动和肌肉力量的改善有关。
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-11-21 DOI: 10.31662/jmaj.2025-0264
Ayaka Matsumoto, Yoshihiro Yoshimura, Hidetaka Wakabayashi, Fumihiko Nagano, Sayuri Shimazu, Yoshifumi Kido, Takenori Hamada, Kouki Yoneda, Takahiro Bise, Aomi Kuzuhara, Ai Shiraishi

Introduction: Polypharmacy is common among hospitalized post-stroke patients and is associated with adverse outcomes, such as decreased physical function and increased risk of drug-related complications. However, the association with functional outcomes, such as activities of daily living (ADLs) and muscle health remains unclear in this population. This study aimed to investigates whether reducing the number of medications during hospitalization is associated with improved ADL and muscle health in post-stroke patients.

Methods: We conducted a retrospective observational study of post-stroke patients with polypharmacy (≥5 medications) undergoing inpatient rehabilitation. Patients were categorized based on whether the number of medications decreased during hospitalization. Outcomes at discharge included the motor domain of the functional independence measure (FIM), handgrip strength, and skeletal muscle mass index (SMI), assessed by bioelectrical impedance analysis. Propensity score (PS) matching and multivariate linear regression was performed to examine associations between medication reduction and each outcome, adjusting for clinically relevant confounders.

Results: A total of 419 patients (mean age 75.9 years; 55.8% male) were included. Medication reduction occurred in 32.5% of patients, with a median decrease of two drugs. After PS matching, the cohort included 212 patients. In the multivariate analysis of this cohort, medication reduction was independently associated with higher FIM-motor scores (β = 0.105, p = 0.006) and greater handgrip strength (β = 0.073, p = 0.043), but were negatively associated with SMI (β = -0.158, p = 0.017).

Conclusions: Medication reduction during hospitalization was associated with improved ADL and muscle strength, but were negatively associated with muscle mass, in post-stroke patients with polypharmacy. Medication optimization may support functional recovery in this population.

多种用药在住院卒中后患者中很常见,并与不良后果相关,如身体功能下降和药物相关并发症风险增加。然而,在这一人群中,与日常生活活动(ADLs)和肌肉健康等功能结果的关系尚不清楚。本研究旨在探讨住院期间减少药物治疗数量是否与卒中后患者ADL和肌肉健康的改善有关。方法:对卒中后多药(≥5种药物)住院康复患者进行回顾性观察研究。根据住院期间药物数量是否减少对患者进行分类。放电时的结果包括运动域的功能独立性测量(FIM)、握力和骨骼肌质量指数(SMI),通过生物电阻抗分析评估。采用倾向评分(PS)匹配和多元线性回归来检验减量用药与每个结果之间的关系,并对临床相关混杂因素进行调整。结果:共纳入419例患者,平均年龄75.9岁,男性55.8%。32.5%的患者减少了用药,中位数减少了两种药物。PS匹配后,纳入212例患者。在该队列的多变量分析中,减少用药与更高的FIM-motor评分(β = 0.105, p = 0.006)和更大的握力(β = 0.073, p = 0.043)独立相关,但与SMI呈负相关(β = -0.158, p = 0.017)。结论:住院期间减少用药与卒中后多药患者ADL和肌肉力量的改善相关,但与肌肉质量呈负相关。药物优化可能支持这一人群的功能恢复。
{"title":"Medication Reduction is Associated with Improved Activities of Daily Living and Muscle Strength in Post-Stroke Patients with Polypharmacy.","authors":"Ayaka Matsumoto, Yoshihiro Yoshimura, Hidetaka Wakabayashi, Fumihiko Nagano, Sayuri Shimazu, Yoshifumi Kido, Takenori Hamada, Kouki Yoneda, Takahiro Bise, Aomi Kuzuhara, Ai Shiraishi","doi":"10.31662/jmaj.2025-0264","DOIUrl":"https://doi.org/10.31662/jmaj.2025-0264","url":null,"abstract":"<p><strong>Introduction: </strong>Polypharmacy is common among hospitalized post-stroke patients and is associated with adverse outcomes, such as decreased physical function and increased risk of drug-related complications. However, the association with functional outcomes, such as activities of daily living (ADLs) and muscle health remains unclear in this population. This study aimed to investigates whether reducing the number of medications during hospitalization is associated with improved ADL and muscle health in post-stroke patients.</p><p><strong>Methods: </strong>We conducted a retrospective observational study of post-stroke patients with polypharmacy (≥5 medications) undergoing inpatient rehabilitation. Patients were categorized based on whether the number of medications decreased during hospitalization. Outcomes at discharge included the motor domain of the functional independence measure (FIM), handgrip strength, and skeletal muscle mass index (SMI), assessed by bioelectrical impedance analysis. Propensity score (PS) matching and multivariate linear regression was performed to examine associations between medication reduction and each outcome, adjusting for clinically relevant confounders.</p><p><strong>Results: </strong>A total of 419 patients (mean age 75.9 years; 55.8% male) were included. Medication reduction occurred in 32.5% of patients, with a median decrease of two drugs. After PS matching, the cohort included 212 patients. In the multivariate analysis of this cohort, medication reduction was independently associated with higher FIM-motor scores (β = 0.105, p = 0.006) and greater handgrip strength (β = 0.073, p = 0.043), but were negatively associated with SMI (β = -0.158, p = 0.017).</p><p><strong>Conclusions: </strong>Medication reduction during hospitalization was associated with improved ADL and muscle strength, but were negatively associated with muscle mass, in post-stroke patients with polypharmacy. Medication optimization may support functional recovery in this population.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"198-208"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889877/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors in Patient-Clinician Interactions That Influence the Decision-Making Process of Older Patients with Dementia. 影响老年痴呆患者决策过程的医患互动因素
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-11-21 DOI: 10.31662/jmaj.2024-0260
Yoshihisa Hirakawa, Kaoruko Aita, Tami Saito, Reiko Ishiyama, Sanae Takanashi, Chiho Shimada, Hisayuki Miura

Introduction: The importance of promoting the autonomy of people with dementia has been globally emphasized. Several studies have investigated factors that impede and facilitate their decision-making. However, few studies have explored these factors in light of their decision-making process. Therefore, this study aimed to determine factors in patient-clinician interactions that influence patient autonomy and participation in decision-making among Japanese patients with dementia.

Methods: The authors adopted qualitative methods to understand the perceptions of health care professionals such as physicians, nurses, physical therapists, care managers, and social workers. Between January and March 2022, individual in-depth interviews were conducted online with 24 health care professionals with ample experience in primary palliative care for dementia. The topics were the support provided in patients' decision-making, the support provided to proxy decision-makers, and the efforts undertaken for building a relationship between patients and families or among multidisciplinary teams. All interviews were audio-recorded electronically and transcribed verbatim. These data were synthesized and analyzed using content analysis.

Results: Four main themes were derived that captured the factors that influence the decision-making process of Japanese patients with dementia in patient-clinician interactions: rapport, decision-making capability, provision of explanation, and presentation of options. The findings highlighted the importance of building rapport with patients through communication in the early stages of dementia, improving patients' decision-making capability and protecting vulnerable patients who cannot make decisions independently, explaining each option's risks and benefits in a comprehensible manner, and presenting a wide range of options to patients in everyday decision-making.

Conclusions: Overall, the themes were in accordance with the process of informed consent. The findings also showed that clinicians must understand the barriers to obtaining informed consent that arise from patients' cognitive impairment, decline, and fluctuations, in addition to cultural factors.

导言:促进痴呆症患者自主性的重要性已在全球得到强调。几项研究调查了阻碍和促进他们决策的因素。然而,很少有研究根据这些因素的决策过程来探讨这些因素。因此,本研究旨在确定影响日本痴呆患者自主和决策参与的医患互动因素。方法:作者采用定性方法了解医生、护士、物理治疗师、护理管理人员和社会工作者等卫生保健专业人员的看法。在2022年1月至3月期间,对24名在痴呆症初级姑息治疗方面经验丰富的卫生保健专业人员进行了在线个人深度访谈。主题是为患者决策提供的支持,为代理决策者提供的支持,以及为建立患者与家属或多学科团队之间的关系所做的努力。所有采访都以电子方式录音,并逐字抄录。利用内容分析法对这些数据进行综合分析。结果:得出了四个主要主题,这些主题捕获了影响日本痴呆症患者在医患互动中的决策过程的因素:融洽关系、决策能力、提供解释和提出选择。研究结果强调了在痴呆症早期通过沟通与患者建立融洽关系的重要性,提高患者的决策能力,保护无法独立做出决策的弱势患者,以可理解的方式解释每种选择的风险和益处,并在日常决策中为患者提供广泛的选择。结论:总体而言,主题符合知情同意流程。研究结果还表明,除了文化因素外,临床医生必须了解由于患者认知障碍、衰退和波动而产生的获得知情同意的障碍。
{"title":"Factors in Patient-Clinician Interactions That Influence the Decision-Making Process of Older Patients with Dementia.","authors":"Yoshihisa Hirakawa, Kaoruko Aita, Tami Saito, Reiko Ishiyama, Sanae Takanashi, Chiho Shimada, Hisayuki Miura","doi":"10.31662/jmaj.2024-0260","DOIUrl":"https://doi.org/10.31662/jmaj.2024-0260","url":null,"abstract":"<p><strong>Introduction: </strong>The importance of promoting the autonomy of people with dementia has been globally emphasized. Several studies have investigated factors that impede and facilitate their decision-making. However, few studies have explored these factors in light of their decision-making process. Therefore, this study aimed to determine factors in patient-clinician interactions that influence patient autonomy and participation in decision-making among Japanese patients with dementia.</p><p><strong>Methods: </strong>The authors adopted qualitative methods to understand the perceptions of health care professionals such as physicians, nurses, physical therapists, care managers, and social workers. Between January and March 2022, individual in-depth interviews were conducted online with 24 health care professionals with ample experience in primary palliative care for dementia. The topics were the support provided in patients' decision-making, the support provided to proxy decision-makers, and the efforts undertaken for building a relationship between patients and families or among multidisciplinary teams. All interviews were audio-recorded electronically and transcribed verbatim. These data were synthesized and analyzed using content analysis.</p><p><strong>Results: </strong>Four main themes were derived that captured the factors that influence the decision-making process of Japanese patients with dementia in patient-clinician interactions: rapport, decision-making capability, provision of explanation, and presentation of options. The findings highlighted the importance of building rapport with patients through communication in the early stages of dementia, improving patients' decision-making capability and protecting vulnerable patients who cannot make decisions independently, explaining each option's risks and benefits in a comprehensible manner, and presenting a wide range of options to patients in everyday decision-making.</p><p><strong>Conclusions: </strong>Overall, the themes were in accordance with the process of informed consent. The findings also showed that clinicians must understand the barriers to obtaining informed consent that arise from patients' cognitive impairment, decline, and fluctuations, in addition to cultural factors.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"173-179"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146167575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frailty Assessed Using the FRAIL-NH Scale and its Associations with Long-Term Care Needs in Residents of Japanese Nursing Homes: A Multicenter Cross-Sectional Study. 使用FRAIL-NH量表评估日本养老院居民的脆弱性及其与长期护理需求的关系:一项多中心横断面研究。
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-11-28 DOI: 10.31662/jmaj.2025-0396
Shota Hamada, Rumiko Tsuchiya-Ito, Shin J Liau, Yukari Hattori, J Simon Bell, Nobuo Sakata

Introduction: Frailty is often considered a pre-disability overall health state. However, even among older adults with disability, assessing frailty can be crucial for providing appropriate support and care services that maintain or promote their remaining independent abilities. The FRAIL-NH scale was developed to assess frailty in nursing home residents and has been shown to be useful in predicting their prognosis. We aimed to determine the prevalence and degree of frailty assessed by the FRAIL-NH scale among nursing home residents in Japan and investigate the associations between frailty status and long-term care (LTC) needs.

Methods: A cross-sectional study was conducted in four nursing homes in the Tokyo metropolitan area of Japan, 2020. Frailty status was assessed using the 7-item FRAIL-NH scale Japanese version: non-frail (0-1 points), frail (2-5 points), and most-frail (6-14 points). Levels of LTC needs at the latest LTC needs certification were obtained from electronic health records. Age- and sex-adjusted multivariable logistic regression analyses were conducted to evaluate the associations between frailty status and the level of LTC needs.

Results: Among 372 residents, 20.7% and 69.9% were frail and most-frail, respectively. Adjusted odds ratios (95% confidence intervals) for being either frail or most-frail were 3.62 (1.31-10.01) and 3.69 (1.14-11.94) for LTC needs levels 4 and 5, respectively, compared to level 3. Similarly, adjusted odds ratios (95% confidence intervals) for most-frail were 3.09 (1.77-5.38) and 6.38 (3.13-13.03) for LTC needs levels 4 and 5, respectively.

Conclusions: Most nursing home residents were assessed as being frail or most-frail. Frailty was strongly associated with LTC needs, indicating important resource implications for care services. Moreover, assessing frailty with the FRAIL-NH scale may support medical and care-related decision-making.

简介:虚弱通常被认为是残疾前的整体健康状态。然而,即使在残疾老年人中,评估虚弱程度对于提供适当的支持和护理服务,维持或促进其剩余的独立能力也至关重要。fail - nh量表是为了评估养老院居民的虚弱程度而开发的,并已被证明对预测他们的预后是有用的。我们的目的是确定日本养老院居民虚弱的患病率和程度,并调查虚弱状态与长期护理(LTC)需求之间的关系。方法:采用横断面研究方法,于2020年在日本东京市区的四家养老院进行研究。虚弱状态采用日本版的7项虚弱量表进行评估:非虚弱(0-1分)、虚弱(2-5分)和最虚弱(6-14分)。在最近的LTC需求认证中,LTC需求水平是从电子健康记录中获得的。进行了年龄和性别调整的多变量logistic回归分析,以评估虚弱状态与LTC需求水平之间的关系。结果:372名居民中,体弱多病者占20.7%,最体弱多病者占69.9%。与级别3相比,LTC需求级别4和5的虚弱或最虚弱的调整优势比(95%置信区间)分别为3.62(1.31-10.01)和3.69(1.14-11.94)。同样,对于最虚弱的患者,LTC需求水平4级和5级的调整优势比(95%置信区间)分别为3.09(1.77-5.38)和6.38(3.13-13.03)。结论:大多数养老院居民被评估为体弱或最体弱。虚弱与长期护理需求密切相关,表明护理服务的重要资源含义。此外,用FRAIL-NH量表评估虚弱程度可以支持医疗和护理相关的决策。
{"title":"Frailty Assessed Using the FRAIL-NH Scale and its Associations with Long-Term Care Needs in Residents of Japanese Nursing Homes: A Multicenter Cross-Sectional Study.","authors":"Shota Hamada, Rumiko Tsuchiya-Ito, Shin J Liau, Yukari Hattori, J Simon Bell, Nobuo Sakata","doi":"10.31662/jmaj.2025-0396","DOIUrl":"https://doi.org/10.31662/jmaj.2025-0396","url":null,"abstract":"<p><strong>Introduction: </strong>Frailty is often considered a pre-disability overall health state. However, even among older adults with disability, assessing frailty can be crucial for providing appropriate support and care services that maintain or promote their remaining independent abilities. The FRAIL-NH scale was developed to assess frailty in nursing home residents and has been shown to be useful in predicting their prognosis. We aimed to determine the prevalence and degree of frailty assessed by the FRAIL-NH scale among nursing home residents in Japan and investigate the associations between frailty status and long-term care (LTC) needs.</p><p><strong>Methods: </strong>A cross-sectional study was conducted in four nursing homes in the Tokyo metropolitan area of Japan, 2020. Frailty status was assessed using the 7-item FRAIL-NH scale Japanese version: non-frail (0-1 points), frail (2-5 points), and most-frail (6-14 points). Levels of LTC needs at the latest LTC needs certification were obtained from electronic health records. Age- and sex-adjusted multivariable logistic regression analyses were conducted to evaluate the associations between frailty status and the level of LTC needs.</p><p><strong>Results: </strong>Among 372 residents, 20.7% and 69.9% were frail and most-frail, respectively. Adjusted odds ratios (95% confidence intervals) for being either frail or most-frail were 3.62 (1.31-10.01) and 3.69 (1.14-11.94) for LTC needs levels 4 and 5, respectively, compared to level 3. Similarly, adjusted odds ratios (95% confidence intervals) for most-frail were 3.09 (1.77-5.38) and 6.38 (3.13-13.03) for LTC needs levels 4 and 5, respectively.</p><p><strong>Conclusions: </strong>Most nursing home residents were assessed as being frail or most-frail. Frailty was strongly associated with LTC needs, indicating important resource implications for care services. Moreover, assessing frailty with the FRAIL-NH scale may support medical and care-related decision-making.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"246-253"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146167692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between Maternal Body Composition during Pregnancy and Newborn Birth Weight in Japan. 日本孕妇身体成分与新生儿体重的关系
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-11-14 DOI: 10.31662/jmaj.2025-0060
Eriko Eto, Masakazu Kato, Satoe Kirino, Chiaki Kuriyama, Shujiro Sakata, Hikari Nakato, Sakurako Mishima, Akiko Ohira, Hisashi Masuyama

Introduction: This study aimed to investigate the changes in maternal body composition during pregnancy in Japanese women and the relationship between maternal body composition and newborn birth weight using pre-pregnancy body mass index (BMI) in all trimesters.

Methods: A total of 1,851 pregnant Japanese women were enrolled in this study. Body composition was measured using TANITA MC-190EM. The associations between newborn birth weight and maternal BMI, fat mass (FM), fat-free mass (FFM), total body water (TBW), muscle mass (MM), FM gain, FFM gain, and weight gain were evaluated.

Results: The participants' age and pre-pregnancy BMI were 34.1 years and 21.4 kg/m2, respectively. Among the patients, 13.4%, 73.0%, 10.3%, and 3.3% were underweight, average weight, overweight, and obese, respectively. The FM showed no significant change from the second to third trimesters in the underweight, overweight, and obese groups. Moreover, the FM in the overweight and obese groups did not change during any period. The FFM, TBW, and MM significantly increased from the first to second and second to third trimesters. In BMI-stratified multivariate regression analyses, FFM in the normal and overweight groups was positively associated with birth weight, whereas FM gain was negatively associated in the underweight and normal groups. No significant associations were observed in the obese group.

Conclusions: Changes in maternal body composition during pregnancy in Japanese women varied by pre-pregnancy BMI. Associations with birth weight also differed by BMI group. Further prospective studies are needed to confirm these relationships and investigate the mechanisms.

前言:本研究旨在利用孕前身体质量指数(BMI)研究日本妇女妊娠期间母体身体成分的变化,以及母体身体成分与新生儿体重的关系。方法:共有1851名日本孕妇参加了这项研究。使用TANITA MC-190EM测量身体成分。评估新生儿体重与母亲BMI、脂肪质量(FM)、无脂质量(FFM)、全身水分(TBW)、肌肉质量(MM)、脂肪质量增加、无脂质量增加和体重增加之间的关系。结果:参与者的年龄和孕前BMI分别为34.1岁和21.4 kg/m2。其中体重不足占13.4%,平均体重占73.0%,超重占10.3%,肥胖占3.3%。在体重过轻、超重和肥胖组中,FM从妊娠中期到妊娠晚期没有显著变化。此外,超重和肥胖组的FM在任何时期都没有变化。FFM、TBW和MM在妊娠早期至中期和中期至晚期显著升高。在bmi分层多变量回归分析中,正常和超重组的FFM与出生体重呈正相关,而体重不足组和正常组的FM增加呈负相关。在肥胖组中没有观察到明显的关联。结论:日本妇女怀孕期间母体身体成分的变化随孕前BMI的变化而变化。与出生体重的关联也因BMI组而异。需要进一步的前瞻性研究来证实这些关系并调查其机制。
{"title":"Relationship between Maternal Body Composition during Pregnancy and Newborn Birth Weight in Japan.","authors":"Eriko Eto, Masakazu Kato, Satoe Kirino, Chiaki Kuriyama, Shujiro Sakata, Hikari Nakato, Sakurako Mishima, Akiko Ohira, Hisashi Masuyama","doi":"10.31662/jmaj.2025-0060","DOIUrl":"https://doi.org/10.31662/jmaj.2025-0060","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the changes in maternal body composition during pregnancy in Japanese women and the relationship between maternal body composition and newborn birth weight using pre-pregnancy body mass index (BMI) in all trimesters.</p><p><strong>Methods: </strong>A total of 1,851 pregnant Japanese women were enrolled in this study. Body composition was measured using TANITA MC-190EM. The associations between newborn birth weight and maternal BMI, fat mass (FM), fat-free mass (FFM), total body water (TBW), muscle mass (MM), FM gain, FFM gain, and weight gain were evaluated.</p><p><strong>Results: </strong>The participants' age and pre-pregnancy BMI were 34.1 years and 21.4 kg/m<sup>2</sup>, respectively. Among the patients, 13.4%, 73.0%, 10.3%, and 3.3% were underweight, average weight, overweight, and obese, respectively. The FM showed no significant change from the second to third trimesters in the underweight, overweight, and obese groups. Moreover, the FM in the overweight and obese groups did not change during any period. The FFM, TBW, and MM significantly increased from the first to second and second to third trimesters. In BMI-stratified multivariate regression analyses, FFM in the normal and overweight groups was positively associated with birth weight, whereas FM gain was negatively associated in the underweight and normal groups. No significant associations were observed in the obese group.</p><p><strong>Conclusions: </strong>Changes in maternal body composition during pregnancy in Japanese women varied by pre-pregnancy BMI. Associations with birth weight also differed by BMI group. Further prospective studies are needed to confirm these relationships and investigate the mechanisms.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"189-197"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Importance of Continuous Monitoring in Identifying Bradycardia during Propranolol Treatment for Infantile Hemangiomas. 婴儿血管瘤普萘洛尔治疗期间持续监测识别心动过缓的重要性。
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-11-28 DOI: 10.31662/jmaj.2025-0213
Yasuhiko Maki, Hiroyuki Iijima, Kazue Yoshida, Akira Ishiguro

Introduction: To clarify whether continuous-monitoring can detect bradycardia during propranolol treatment for infantile hemangioma (IH) and explore management practices for patients with bradycardia.

Methods: This retrospective study with historic controls was conducted on children with IH aged 0-1 year admitted for propranolol treatment at the National Center for Child Health and Development between October 2016 and July 2023. Patients were divided into two groups based on the monitoring method, namely, the spot-measurement group (October 2016 to August 2018) and the continuous-monitoring group (September 2018 to July 2023). Bradycardia was defined as a heart rate of <90/min lasting for 20 minutes. Patient data included clinical characteristics, propranolol dosage, and adverse effects (bradycardia, hypotension, and hypoglycemia). Statistical analyses were performed using Fisher's exact and Mann-Whitney U tests.

Results: During the study period, 106 patients were admitted for propranolol therapy; 49 were in the spot-measurement group and 57 in the continuous-monitoring group. The frequency of bradycardia was significantly higher in the continuous-monitoring group than in the spot-measurement group (21% vs. 2%, p = 0.003). In the continuous-monitoring group, 2 of 12 patients with bradycardia were symptomatic. All patients experienced prompt resolution of symptoms with the reduction of propranolol dosage and had favorable outcomes for IH.

Conclusions: Continuous-monitoring can detect bradycardia more effectively during propranolol treatment for IH than spot-measurement, and reducing the dosage of propranolol can lead to favorable outcomes for IH while minimizing the risk of bradycardia.

前言:阐明持续监测是否可以检测到婴儿血管瘤(IH)在心得安治疗期间的心动过缓,并探讨心动过缓患者的管理方法。方法:对2016年10月至2023年7月在国家儿童健康与发展中心接受心得安治疗的0-1岁IH患儿进行回顾性研究,并进行历史对照。根据监测方法将患者分为两组,即点测组(2016年10月至2018年8月)和连续监测组(2018年9月至2023年7月)。心动过缓被定义为心率U试验。结果:研究期间,106例患者接受心得安治疗;点测组49例,连续监测组57例。持续监测组发生心动过缓的频率明显高于定点测量组(21% vs. 2%, p = 0.003)。在持续监测组,12例心动过缓患者中有2例出现症状。随着心得安剂量的减少,所有患者症状均迅速缓解,IH预后良好。结论:在心得安治疗IH期间,持续监测能比现场监测更有效地检测到心动过缓,减少心得安的剂量可在降低心动过缓风险的同时获得良好的IH预后。
{"title":"The Importance of Continuous Monitoring in Identifying Bradycardia during Propranolol Treatment for Infantile Hemangiomas.","authors":"Yasuhiko Maki, Hiroyuki Iijima, Kazue Yoshida, Akira Ishiguro","doi":"10.31662/jmaj.2025-0213","DOIUrl":"https://doi.org/10.31662/jmaj.2025-0213","url":null,"abstract":"<p><strong>Introduction: </strong>To clarify whether continuous-monitoring can detect bradycardia during propranolol treatment for infantile hemangioma (IH) and explore management practices for patients with bradycardia.</p><p><strong>Methods: </strong>This retrospective study with historic controls was conducted on children with IH aged 0-1 year admitted for propranolol treatment at the National Center for Child Health and Development between October 2016 and July 2023. Patients were divided into two groups based on the monitoring method, namely, the spot-measurement group (October 2016 to August 2018) and the continuous-monitoring group (September 2018 to July 2023). Bradycardia was defined as a heart rate of <90/min lasting for 20 minutes. Patient data included clinical characteristics, propranolol dosage, and adverse effects (bradycardia, hypotension, and hypoglycemia). Statistical analyses were performed using Fisher's exact and Mann-Whitney <i>U</i> tests.</p><p><strong>Results: </strong>During the study period, 106 patients were admitted for propranolol therapy; 49 were in the spot-measurement group and 57 in the continuous-monitoring group. The frequency of bradycardia was significantly higher in the continuous-monitoring group than in the spot-measurement group (21% vs. 2%, p = 0.003). In the continuous-monitoring group, 2 of 12 patients with bradycardia were symptomatic. All patients experienced prompt resolution of symptoms with the reduction of propranolol dosage and had favorable outcomes for IH.</p><p><strong>Conclusions: </strong>Continuous-monitoring can detect bradycardia more effectively during propranolol treatment for IH than spot-measurement, and reducing the dosage of propranolol can lead to favorable outcomes for IH while minimizing the risk of bradycardia.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"302-308"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889071/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Qualitative and Quantitative Estimation of Ceftriaxone in Pharmaceutical Dosage Forms Using Reverse Phase High Performance Liquid Chromatography. 反相高效液相色谱法定性定量评价头孢曲松在制剂中的含量。
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-12-05 DOI: 10.31662/jmaj.2025-0309
Hibba Dar, Rehana Tabassum, Younis Rather, Sameena Farhat

Introduction: As the "pharmacy of the world," India plays a critical role in global pharmaceutical supply. However, increasing reports of substandard and falsified medicines raise serious concerns. With Jammu and Kashmir witnessing repeated quality failures of ceftriaxone, this study aims to verify its quality using a refined high-performance liquid chromatography (HPLC)-based analytical method.

Methods: The ceftriaxone assay was performed using Agilent 1260 Infinity HPLC System with a C18 column and EZChromS1 software. A solvent system of acetonitrile and water (20:80, v/v) was used, with flow rate of 0.5 mL/min and ultraviolet detection at 254 nm. Standard solutions (20-70 μg/mL) were prepared from a 1,000 μg/mL stock for calibration. Nineteen injectable ceftriaxone brands were procured and coded for anonymity. Sample solutions were prepared at 50 μg/mL. The method was validated as per International Council for Harmonisation (ICH) guidelines for accuracy, precision, linearity, specificity, limit of detection (LOD), limit of quantification (LOQ), and robustness. Solution stability was assessed over 7 days at 2°C-8°C.

Results: The developed isocratic reversed-phase HPLC method showed good linearity (R2 = 0.9991) over the range 20-70 μg/mL, with LOD and LOQ of 5.88 μg/mL and 17.83 μg/mL, respectively. Intra-day and inter-day precision and accuracy showed percentage relative standard deviation (%RSD) values <2% and mean recovery within acceptable limits (96.9%-102.6%). Robustness was confirmed through variations in flow rate, mobile phase composition, detection wavelength, and column temperature, all yielding %RSD <2%. Analysis of 19 marketed formulations revealed that 89.5% complied with pharmacopoeial standards (90.0%-115.0% recovery), while 10.5% (CEF A17, CEF A19) were substandard, indicating significant quality variation among brands (p < 0.05).

Conclusions: A simple, sensitive, and cost-effective HPLC method was developed and validated for estimation of ceftriaxone in pharmaceutical dosage forms. Among 19 tested formulations, 89.5% complied with Indian Pharmacopoeial standards, while two formulations were found substandard, indicating variability in product quality.

引言:作为“世界药房”,印度在全球药品供应中起着至关重要的作用。然而,越来越多的伪劣药品报告引发了严重的担忧。鉴于查谟和克什米尔地区头孢曲松屡屡出现质量问题,本研究旨在利用基于高效液相色谱(HPLC)的精确化分析方法验证其质量。方法:采用Agilent 1260无极高效液相色谱系统,C18柱,EZChromS1软件进行头孢曲松检测。采用乙腈-水(20:80,v/v)溶剂体系,流速0.5 mL/min,紫外检测波长254 nm。从1000 μg/mL的原液中制备20-70 μg/mL的标准溶液进行校准。获得了19个注射用头孢曲松品牌,并进行了匿名编码。样品溶液浓度为50 μg/mL。根据国际协调委员会(ICH)的准确性、精密度、线性、特异性、检出限(LOD)、定量限(LOQ)和鲁棒性指南对该方法进行了验证。在2°C-8°C下评估溶液稳定性7天。结果:该方法在20 ~ 70 μg/mL范围内线性良好(R2 = 0.9991),定量限为5.88 μg/mL,定量限为17.83 μg/mL。结论:建立了一种简便、灵敏、成本合理的高效液相色谱法测定头孢曲松制剂中头孢曲松的含量。在19个被检测的制剂中,89.5%符合印度药典标准,2个制剂不合格,说明产品质量存在差异。
{"title":"Qualitative and Quantitative Estimation of Ceftriaxone in Pharmaceutical Dosage Forms Using Reverse Phase High Performance Liquid Chromatography.","authors":"Hibba Dar, Rehana Tabassum, Younis Rather, Sameena Farhat","doi":"10.31662/jmaj.2025-0309","DOIUrl":"https://doi.org/10.31662/jmaj.2025-0309","url":null,"abstract":"<p><strong>Introduction: </strong>As the \"pharmacy of the world,\" India plays a critical role in global pharmaceutical supply. However, increasing reports of substandard and falsified medicines raise serious concerns. With Jammu and Kashmir witnessing repeated quality failures of ceftriaxone, this study aims to verify its quality using a refined high-performance liquid chromatography (HPLC)-based analytical method.</p><p><strong>Methods: </strong>The ceftriaxone assay was performed using Agilent 1260 Infinity HPLC System with a C18 column and EZChromS1 software. A solvent system of acetonitrile and water (20:80, v/v) was used, with flow rate of 0.5 mL/min and ultraviolet detection at 254 nm. Standard solutions (20-70 μg/mL) were prepared from a 1,000 μg/mL stock for calibration. Nineteen injectable ceftriaxone brands were procured and coded for anonymity. Sample solutions were prepared at 50 μg/mL. The method was validated as per International Council for Harmonisation (ICH) guidelines for accuracy, precision, linearity, specificity, limit of detection (LOD), limit of quantification (LOQ), and robustness. Solution stability was assessed over 7 days at 2°C-8°C.</p><p><strong>Results: </strong>The developed isocratic reversed-phase HPLC method showed good linearity (R<sup>2</sup> = 0.9991) over the range 20-70 μg/mL, with LOD and LOQ of 5.88 μg/mL and 17.83 μg/mL, respectively. Intra-day and inter-day precision and accuracy showed percentage relative standard deviation (%RSD) values <2% and mean recovery within acceptable limits (96.9%-102.6%). Robustness was confirmed through variations in flow rate, mobile phase composition, detection wavelength, and column temperature, all yielding %RSD <2%. Analysis of 19 marketed formulations revealed that 89.5% complied with pharmacopoeial standards (90.0%-115.0% recovery), while 10.5% (CEF A17, CEF A19) were substandard, indicating significant quality variation among brands (p < 0.05).</p><p><strong>Conclusions: </strong>A simple, sensitive, and cost-effective HPLC method was developed and validated for estimation of ceftriaxone in pharmaceutical dosage forms. Among 19 tested formulations, 89.5% complied with Indian Pharmacopoeial standards, while two formulations were found substandard, indicating variability in product quality.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"292-301"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Pressure, Urinalysis, and Edema Assessment in Perinatal Care: From Historical Foundations to Evidence-Based Practice. 围产儿护理中的血压、尿液分析和水肿评估:从历史基础到循证实践。
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-11-21 DOI: 10.31662/jmaj.2025-0241
Yoshitsugu Chigusa, Kazuki Yamano, Taito Miyamoto, Haruta Mogami, Masaki Mandai, Hirohito Metoki, Akihiko Sekizawa

The triad of blood pressure measurement, urinalysis, and edema assessment has constituted the cornerstone of prenatal care for over eight decades and has been consistently recorded at each examination in Japan's Maternal and Child Health Handbook. Historically, these examinations were prioritized to facilitate the early diagnosis and treatment of pregnancy toxemia-now termed hypertensive disorders of pregnancy-which once represented a leading cause of maternal mortality. The triad has undeniably played a pivotal role in the early diagnosis, prediction, and treatment of hypertensive disorders of pregnancy, while potentially contributing to the detection of other obstetric complications. However, conclusive evidence linking these conventionally performed assessments to actual pregnancy and delivery outcomes remains limited, and critical unresolved issues persist within each examination category. Blood pressure assessment requires the establishment of optimal blood pressure thresholds to achieve favorable pregnancy and perinatal outcomes; to achieve this, home blood pressure monitoring should be adopted. Evidence-based target blood pressure ranges for treatment initiation in hypertensive disorders of pregnancy and therapeutic targets are urgently needed. For urinary protein assessment, the establishment of standardized criteria for postpartum proteinuria follow-up is essential. In terms of edema, critical evidence is lacking regarding the evaluation and treatment of pathological edema that adversely affects pregnancy outcomes. This review traces the historical evolution of these examinations while critically examining their contemporary role in perinatal care. A notable characteristic of this triad is its noninvasive nature and minimal cost burden. The establishment of robust evidence supporting their clinical utility could optimize maternal and fetal outcomes while maintaining cost-effective healthcare delivery.

血压测量、尿液分析和水肿评估三位一体构成了80多年来产前护理的基石,并在日本《妇幼保健手册》的每次检查中始终记录下来。从历史上看,这些检查的重点是促进妊娠毒血症的早期诊断和治疗——现在称为妊娠高血压疾病——这曾经是孕产妇死亡的主要原因。不可否认,三联征在妊娠期高血压疾病的早期诊断、预测和治疗中发挥了关键作用,同时可能有助于发现其他产科并发症。然而,将这些常规评估与实际妊娠和分娩结果联系起来的结论性证据仍然有限,并且在每个检查类别中仍然存在未解决的关键问题。血压评估需要建立最佳血压阈值,以实现良好的妊娠和围产期结局;为此,应采用家庭血压监测。妊娠期高血压疾病起始治疗的循证目标血压范围和治疗靶点是迫切需要的。对于尿蛋白的评估,建立标准化的产后蛋白尿随访标准至关重要。在水肿方面,缺乏对影响妊娠结局的病理性水肿的评估和治疗的关键证据。这篇综述追溯了这些检查的历史演变,同时批判性地考察了它们在围产期护理中的当代作用。这种三位一体的显著特点是其非侵入性和最小的成本负担。建立强有力的证据支持其临床应用,可以优化产妇和胎儿的结局,同时保持具有成本效益的医疗服务。
{"title":"Blood Pressure, Urinalysis, and Edema Assessment in Perinatal Care: From Historical Foundations to Evidence-Based Practice.","authors":"Yoshitsugu Chigusa, Kazuki Yamano, Taito Miyamoto, Haruta Mogami, Masaki Mandai, Hirohito Metoki, Akihiko Sekizawa","doi":"10.31662/jmaj.2025-0241","DOIUrl":"https://doi.org/10.31662/jmaj.2025-0241","url":null,"abstract":"<p><p>The triad of blood pressure measurement, urinalysis, and edema assessment has constituted the cornerstone of prenatal care for over eight decades and has been consistently recorded at each examination in Japan's Maternal and Child Health Handbook. Historically, these examinations were prioritized to facilitate the early diagnosis and treatment of pregnancy toxemia-now termed hypertensive disorders of pregnancy-which once represented a leading cause of maternal mortality. The triad has undeniably played a pivotal role in the early diagnosis, prediction, and treatment of hypertensive disorders of pregnancy, while potentially contributing to the detection of other obstetric complications. However, conclusive evidence linking these conventionally performed assessments to actual pregnancy and delivery outcomes remains limited, and critical unresolved issues persist within each examination category. Blood pressure assessment requires the establishment of optimal blood pressure thresholds to achieve favorable pregnancy and perinatal outcomes; to achieve this, home blood pressure monitoring should be adopted. Evidence-based target blood pressure ranges for treatment initiation in hypertensive disorders of pregnancy and therapeutic targets are urgently needed. For urinary protein assessment, the establishment of standardized criteria for postpartum proteinuria follow-up is essential. In terms of edema, critical evidence is lacking regarding the evaluation and treatment of pathological edema that adversely affects pregnancy outcomes. This review traces the historical evolution of these examinations while critically examining their contemporary role in perinatal care. A notable characteristic of this triad is its noninvasive nature and minimal cost burden. The establishment of robust evidence supporting their clinical utility could optimize maternal and fetal outcomes while maintaining cost-effective healthcare delivery.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"40-51"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunity and Identity: From the Arterial Wall to the Architecture of Self. 免疫与同一性:从动脉壁到自我建筑。
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2026-01-09 DOI: 10.31662/jmaj.2025-0541
Atsushi Mizuno
{"title":"Immunity and Identity: From the Arterial Wall to the Architecture of Self.","authors":"Atsushi Mizuno","doi":"10.31662/jmaj.2025-0541","DOIUrl":"https://doi.org/10.31662/jmaj.2025-0541","url":null,"abstract":"","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"38-39"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889082/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unpaid Medical Expenses by Foreign Patients in Japan: A Scoping Review. 在日本的外国患者未付医疗费用:一项范围审查。
IF 1.8 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-15 Epub Date: 2025-12-26 DOI: 10.31662/jmaj.2024-0418
Soichiro Saeki, Hatsune Kido, Chihaya Hinohara, Yan Zhang, Eri Yamada, Kaori Minamitani, Ryo Kawasaki

Background: The increase in international tourists and residents in Japan has necessitated Japanese medical institutions to extend their services to patients, presenting new challenges such as unpaid medical bills. The treatment of foreign patients is further complicated by linguistic, cultural, and social barriers, which heighten the risk of unpaid bills. This highlights the critical need to examine the issue of unpaid medical bills in the context of foreign patient care in Japan. This study investigates trends in research, the regions most affected, and the impact of unpaid medical expenses on patients and healthcare institutions.

Methods: A scoping review was conducted using articles indexed in MEDLINE, Web of Science, Scopus, CINAHL Plus, Ichushi-Web (Japanese medical literature), and Google Scholar, with a focus on publications from Japan discussing unpaid medical bills with foreign patients.

Results: Seventeen publications met the criteria, highlighting the difficulties in collecting medical expenses from foreign patients. Prevention methods, such as prepayment and presenting estimated costs before care were suggested but had limited success. There are also few policies to assist medical institutions with outstanding expenses from foreign patients.

Conclusions: This study underscores the urgent need for comprehensive strategies to address unpaid medical bills among foreign patients in Japan, emphasizing further research to develop effective interventions and enhance the overall healthcare experience for these patients.

背景:日本国际游客和居民的增加,使得日本医疗机构必须将服务范围扩大到患者,这就带来了诸如医疗费用未付等新的挑战。外国患者的治疗因语言、文化和社会障碍而更加复杂,这增加了未付账单的风险。这突出表明,迫切需要在日本外国病人护理的背景下审查未付医药费问题。本研究调查研究趋势、受影响最严重的地区,以及未付医疗费用对患者和医疗机构的影响。方法:对MEDLINE、Web of Science、Scopus、CINAHL Plus、Ichushi-Web(日本医学文献)和谷歌Scholar检索的文章进行范围综述,重点关注来自日本的讨论外国患者未付医药费的出版物。结果:17份出版物符合标准,突出了向外国患者收取医疗费用的困难。建议采取预防措施,如预付费用和在护理前提出估计费用,但收效有限。此外,也没有什么政策来帮助医疗机构处理外国患者的未付费用。结论:本研究强调迫切需要制定综合策略来解决在日外国患者的未付医药费问题,强调进一步研究以制定有效的干预措施并提高这些患者的整体医疗体验。
{"title":"Unpaid Medical Expenses by Foreign Patients in Japan: A Scoping Review.","authors":"Soichiro Saeki, Hatsune Kido, Chihaya Hinohara, Yan Zhang, Eri Yamada, Kaori Minamitani, Ryo Kawasaki","doi":"10.31662/jmaj.2024-0418","DOIUrl":"https://doi.org/10.31662/jmaj.2024-0418","url":null,"abstract":"<p><strong>Background: </strong>The increase in international tourists and residents in Japan has necessitated Japanese medical institutions to extend their services to patients, presenting new challenges such as unpaid medical bills. The treatment of foreign patients is further complicated by linguistic, cultural, and social barriers, which heighten the risk of unpaid bills. This highlights the critical need to examine the issue of unpaid medical bills in the context of foreign patient care in Japan. This study investigates trends in research, the regions most affected, and the impact of unpaid medical expenses on patients and healthcare institutions.</p><p><strong>Methods: </strong>A scoping review was conducted using articles indexed in MEDLINE, Web of Science, Scopus, CINAHL Plus, Ichushi-Web (Japanese medical literature), and Google Scholar, with a focus on publications from Japan discussing unpaid medical bills with foreign patients.</p><p><strong>Results: </strong>Seventeen publications met the criteria, highlighting the difficulties in collecting medical expenses from foreign patients. Prevention methods, such as prepayment and presenting estimated costs before care were suggested but had limited success. There are also few policies to assist medical institutions with outstanding expenses from foreign patients.</p><p><strong>Conclusions: </strong>This study underscores the urgent need for comprehensive strategies to address unpaid medical bills among foreign patients in Japan, emphasizing further research to develop effective interventions and enhance the overall healthcare experience for these patients.</p>","PeriodicalId":73550,"journal":{"name":"JMA journal","volume":"9 1","pages":"10-23"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMA journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1